Mar 07, 2022 / 07:50PM GMT
Daniel Gregory Brennan - Cowen and Company, LLC, Research Division - Research Analyst
Good afternoon. Welcome to Day 1 of the Cowen Health Care Conference. I'm Dan Brennan. I'm one of the 3 tools and diagnostics analysts here. Recently joined, really thrilled to be here and thrilled to have CEO Francis deSouza, President and CEO that is, of Illumina with us here on the virtual stage to present. So Francis, I wanted to say welcome and thank you for being here.
Francis A. deSouza - Illumina, Inc. - CEO & Director
Dan, thanks for having me, and thank you, everyone, for attending this. Maybe before we start, I should get the safe harbor statement out. So let me just start with that.
I have been asked to remind you that my comments today could include forward-looking statements. You should refer to our SEC filings for a discussion of the risks and uncertainties that could cause results to differ materially from our current expectations. It is our intent that all forward-looking statements regarding our financial results and commercial activity made
Illumina Inc at Cowen Health Care Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot